Targeted News Service

Litigation: SEC Vs. Rapid Therapeutic Science Laboratories, Donal R. Schmidt Jr.
September 19, 2023

WASHINGTON, Sept. 19 -- The Securities and Exchange Commission issued the following litigation release (No. 3:23-cv-02081; N.D. Tex. filed Sept. 18, 2023) involving Rapid Therapeutic Science Laboratories Inc. and Donal R. Schmidt Jr.:

* * *

SEC Charges Texas CBD-Inhaler Company and Its CEO in Fraudulent Securities Offerings

* * *

The Securities and Exchange Commission announced that on September 18, 2023, it filed a civil action in U.S. Distric . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form